The global demand for Sexually Transmitted Diseases (STD) Testing Market is presumed to reach the market size of nearly USD 151.89 BN by 2030 from USD 89.73 BN in 2022 with a CAGR of 6.8% under the study period of 2023 - 2030. Regarding volume, the market was calculated XX Million Tests in 2022 and forecast to touch XX Million Tests by 2030 with a CAGR of XX% during 2023-2030.
Sexually transmitted diseases (STD) testing refers to the medical screening and diagnostic procedures conducted to detect the presence of sexually transmitted infections or diseases in individuals. It involves the analysis of samples, such as blood, urine, swabs, or tissue, to identify the presence of pathogens or antibodies associated with specific STDs.
The Sexually transmitted diseases (STD) testing market is driven by various factors. Firstly, the rising prevalence of sexually transmitted infections globally has created a greater demand for testing services. Factors such as changing sexual behaviours and inadequate preventive measures contribute to the spread of STDs, necessitating regular screening and early detection. Additionally, increasing awareness and education about the importance of STD testing have led to a higher emphasis on screening. Government initiatives and healthcare policies that offer free or subsidized testing services, along with technological advancements in testing methods, have also contributed to market growth. Changing social and cultural factors have reduced the stigma associated with STDs, leading to more open discussions about sexual health and an increased willingness to seek testing services. High-risk populations, screening guidelines, and the focus on preventive healthcare have further fueled the demand for STD testing. Overall, the market is driven by the need for early detection, prevention, and management of sexually transmitted infections, as well as increased awareness and accessibility of testing services.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of sexually transmitted diseases (std) testing. The growth and trends of Sexually Transmitted Diseases (STD) Testing Industry provide a holistic approach to this study.
This section of the sexually transmitted diseases (std) testing market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Disease Type
By Location Of Testing
This section covers the regional outlook, which accentuates current and future demand for the Sexually Transmitted Diseases (STD) Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the sexually transmitted diseases (std) testing market include Abbott Laboratories, Becton Dickinson Company, Biomérieux, Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Diasorin Molecular LLc, Hologic Inc., Orasure Technologies, Inc., Roche Holdings AG, Thermo Fisher Scientific (AFFYMETRIX). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . SEXUALLY TRANSMITTED DISEASES (STD) TESTING – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Disease Type
3.7.2 Market Attractiveness Analysis By Location Of Testing
3.7.3 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET ANALYSIS BY DISEASE TYPE
5.1 Overview by Disease Type
5.2 Historical and Forecast Data
5.3 Analysis by Disease Type
5.4 Chlamydia Historic and Forecast Sales by Regions
5.5 Gonorrhea Historic and Forecast Sales by Regions
5.6 Herpes Simplex Virus Historic and Forecast Sales by Regions
5.7 Syphilis Historic and Forecast Sales by Regions
5.8 Human Papillomavirus (HPV) Historic and Forecast Sales by Regions
5.9 Other Diseases (Human Immunodeficiency Virus (HIV), Chancroid, Trichomoniasis, And Hepatitis B) Historic and Forecast Sales by Regions
6 . GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET ANALYSIS BY LOCATION OF TESTING
6.1 Overview by Location Of Testi ...